{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:54:58Z","timestamp":1794272098584,"version":"4.9.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401649"],"award-info":[{"award-number":["82401649"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230040"],"award-info":[{"award-number":["82230040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752018"],"award-info":[{"award-number":["2024M752018"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01195-6","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:15:53Z","timestamp":1764764153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Whole-exome sequencing and burden analysis identify six novel candidate risk genes and expand the genetic landscape of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Yu","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-qin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-jin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"1195_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa, E., Garrido, A., Scholz, S. W. & Poewe, W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 20, 385\u2013397 (2021).","journal-title":"Lancet Neurol."},{"key":"1195_CR2","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 15, 1257\u20131272 (2016).","journal-title":"Lancet Neurol."},{"key":"1195_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","volume":"5","author":"E Tolosa","year":"2006","unstructured":"Tolosa, E., Wenning, G. & Poewe, W. The diagnosis of Parkinson\u2019s disease. Lancet Neurol. 5, 75\u201386 (2006).","journal-title":"Lancet Neurol."},{"key":"1195_CR4","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii, A., Nutt, J. G. & Ransom, B. R. Parkinson\u2019s disease. Lancet 363, 1783\u20131793 (2004).","journal-title":"Lancet"},{"key":"1195_CR5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic, J. Parkinson\u2019s disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79, 368\u2013376 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1195_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","volume":"18","author":"H Ye","year":"2023","unstructured":"Ye, H., Robak, L. A., Yu, M., Cykowski, M. & Shulman, J. M. Genetics and Pathogenesis of Parkinson\u2019s Syndrome. Annu. Rev. Pathol. 18, 95\u2013121 (2023).","journal-title":"Annu. Rev. Pathol."},{"key":"1195_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/bmb\/ldad035","volume":"149","author":"L Trevisan","year":"2024","unstructured":"Trevisan, L. et al. Genetics in Parkinson\u2019s disease, state-of-the-art and future perspectives. Br. Med. Bull. 149, 60\u201371 (2024).","journal-title":"Br. Med. Bull."},{"key":"1195_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","volume":"19","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat, C., Nalls, M. A. & Singleton, A. B. The genetic architecture of Parkinson\u2019s disease. Lancet Neurol. 19, 170\u2013178 (2020).","journal-title":"Lancet Neurol."},{"key":"1195_CR9","doi-asserted-by":"publisher","first-page":"1023574","DOI":"10.3389\/fnagi.2022.1023574","volume":"14","author":"J Dulski","year":"2022","unstructured":"Dulski, J., Uitti, R. J., Ross, O. A. & Wszolek, Z. K. Genetic architecture of Parkinson\u2019s disease subtypes - Review of the literature. Front. aging Neurosci. 14, 1023574 (2022).","journal-title":"Front. aging Neurosci."},{"key":"1195_CR10","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic, J. & Tan, E. K. Parkinson\u2019s disease: etiopathogenesis and treatment. J. Neurol. Neurosurg. Psychiatry 91, 795\u2013808 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1195_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","volume":"226","author":"C Raza","year":"2019","unstructured":"Raza, C., Anjum, R. & Shakeel, N. U. A. Parkinson\u2019s disease: Mechanisms, translational models and management strategies. Life Sci. 226, 77\u201390 (2019).","journal-title":"Life Sci."},{"key":"1195_CR12","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"1195_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41588-023-01584-8","volume":"56","author":"JJ Kim","year":"2024","unstructured":"Kim, J. J. et al. Multi-ancestry genome-wide association meta-analysis of Parkinson\u2019s disease. Nat. Genet. 56, 27\u201336 (2024).","journal-title":"Nat. Genet."},{"key":"1195_CR14","unstructured":"Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nature Genet. 45, 580\u2013585, (2013)."},{"key":"1195_CR15","doi-asserted-by":"publisher","first-page":"139858","DOI":"10.1016\/j.ijbiomac.2025.139858","volume":"297","author":"G Wang","year":"2025","unstructured":"Wang, G. et al. Identification and validation of Atp5f1c in CD4(+) T cell as a hub protein in Parkinson\u2019s disease. Int. J. Biol. Macromol. 297, 139858 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"1195_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1126\/science.adq6650","volume":"388","author":"G Minakaki","year":"2025","unstructured":"Minakaki, G. et al. Commander complex regulates lysosomal function and is implicated in Parkinson\u2019s disease risk. Science 388, 204\u2013211 (2025).","journal-title":"Science"},{"key":"1195_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ana.24410","volume":"78","author":"V Carelli","year":"2015","unstructured":"Carelli, V. et al. Syndromic parkinsonism and dementia associated with OPA1 missense mutations. Ann. Neurol. 78, 21\u201338 (2015).","journal-title":"Ann. Neurol."},{"key":"1195_CR18","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1093\/brain\/awad214","volume":"146","author":"MB Makarious","year":"2023","unstructured":"Makarious, M. B. et al. Large-scale rare variant burden testing in Parkinson\u2019s disease. Brain 146, 4622\u20134632 (2023).","journal-title":"Brain"},{"key":"1195_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106-107","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam, S. R. & Chesselet, M. F. Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog. Neurobiol. 106-107, 17\u201332 (2013).","journal-title":"Prog. Neurobiol."},{"key":"1195_CR20","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1212\/NXG.0000000000000188","volume":"3","author":"DS Lynch","year":"2017","unstructured":"Lynch, D. S. et al. Nonsyndromic Parkinson disease in a family with autosomal dominant optic atrophy due to OPA1 mutations. Neurol. Genet. 3, e188 (2017).","journal-title":"Neurol. Genet."},{"key":"1195_CR21","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/ana.25221","volume":"83","author":"M Jonikas","year":"2018","unstructured":"Jonikas, M. et al. Stem cell modeling of mitochondrial Parkinsonism reveals key functions of OPA1. Ann. Neurol. 83, 915\u2013925 (2018).","journal-title":"Ann. Neurol."},{"key":"1195_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tins.2018.11.001","volume":"42","author":"M Nguyen","year":"2019","unstructured":"Nguyen, M., Wong, Y. C., Ysselstein, D., Severino, A. & Krainc, D. Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson\u2019s disease. Trends Neurosci. 42, 140\u2013149 (2019).","journal-title":"Trends Neurosci."},{"key":"1195_CR23","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.3233\/JPD-212739","volume":"11","author":"A Abeliovich","year":"2021","unstructured":"Abeliovich, A., Hefti, F. & Sevigny, J. Gene therapy for Parkinson\u2019s disease associated with GBA1 mutations. J. Parkinson\u2019s Dis. 11, S183\u2013s188 (2021).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"1195_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"1195_CR25","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599, 628\u2013634 (2021).","journal-title":"Nature"},{"key":"1195_CR26","doi-asserted-by":"publisher","unstructured":"Program, T. G. P. s. G. & Leonard, H. L. Novel Parkinson\u2019s Disease genetic risk factors within and across European populations. 2025.2003.2014.24319455, https:\/\/doi.org\/10.1101\/2025.03.14.24319455 %J medRxiv (2025).","DOI":"10.1101\/2025.03.14.24319455"},{"key":"1195_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. GigaScience 10, giab008 (2021).","journal-title":"GigaScience"},{"key":"1195_CR28","first-page":"None","volume":"2","author":"EJ Gardner","year":"2022","unstructured":"Gardner, E. J. et al. Damaging missense variants in IGF1R implicate a role for IGF-1 resistance in the etiology of type 2 diabetes. Cell Genom. 2, None (2022).","journal-title":"Cell Genom."},{"key":"1195_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"1195_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis, N. M. et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 99, 877\u2013885 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"1195_CR31","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886\u2013d894 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1195_CR32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"1195_CR33","doi-asserted-by":"publisher","first-page":"eadg7492","DOI":"10.1126\/science.adg7492","volume":"381","author":"J Cheng","year":"2023","unstructured":"Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science 381, eadg7492 (2023).","journal-title":"Science"},{"key":"1195_CR34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-022-04558-8","volume":"604","author":"J Morales","year":"2022","unstructured":"Morales, J. et al. A joint NCBI and EMBL-EBI transcript set for clinical genomics and research. Nature 604, 310\u2013315 (2022).","journal-title":"Nature"},{"key":"1195_CR35","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41588-021-00870-7","volume":"53","author":"J Mbatchou","year":"2021","unstructured":"Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet. 53, 1097\u20131103 (2021).","journal-title":"Nat. Genet."},{"key":"1195_CR36","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41588-024-01694-x","volume":"56","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Protein-truncating variants in BSN are associated with severe adult-onset obesity, type 2 diabetes and fatty liver disease. Nat. Genet. 56, 579\u2013584 (2024).","journal-title":"Nat. Genet."},{"key":"1195_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ajhg.2011.05.029","volume":"89","author":"MC Wu","year":"2011","unstructured":"Wu, M. C. et al. Rare-variant association testing for sequencing data with the sequence kernel association test. Am. J. Hum. Genet. 89, 82\u201393 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"1195_CR38","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/biostatistics\/kxs014","volume":"13","author":"S Lee","year":"2012","unstructured":"Lee, S., Wu, M. C. & Lin, X. Optimal tests for rare variant effects in sequencing association studies. Biostatistics 13, 762\u2013775 (2012).","journal-title":"Biostatistics"},{"key":"1195_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ajhg.2019.11.012","volume":"106","author":"Z Zhao","year":"2020","unstructured":"Zhao, Z. et al. UK Biobank Whole-Exome Sequence Binary Phenome Analysis with Robust Region-Based Rare-Variant Test. Am. J. Hum. Genet. 106, 3\u201312 (2020).","journal-title":"Am. J. Hum. Genet."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01195-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01195-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01195-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T12:15:54Z","timestamp":1764764154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01195-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1195"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01195-6","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"347"}}